Children’s Scabies. Problem to be Solved
https://doi.org/10.36107/hfb.2019.i4.s252
Abstract
In Russia, there are currently no drugs for the treatment of infants’ scabies. The serious situation in the country requires the Ministry of Health to decide on the possibility of using permethrin for this purpose. The only drug previously approved for the treatment of scabies in children under one year old (esbiol + piperonyl butoxide, Spregal, France) has not been re-registered in Russia, has not been included in the State Register of Medicines and has not been exported to the country since 2014. An analysis of Cochrane reviews and foreign articles shows that in America, Europe and Japan, the first-line drug for treating scabies in children is 5 % permethrin cream. A domestic drug based on it is 0.4 % aqueous permethrin emulsion (medifox). The authors previously proved its high effectiveness in the treatment of scabies.
About the Authors
T. V. Sokolova
Moscow State University of Food Production
Russian Federation
Russian Federation
Tatiana V. Sokolova
11 Volokolamskoe highway, Moscow, 125080, Russian Federation
A. P. Malyarchuk
Moscow State University of Food Production
Russian Federation
Russian Federation
Alеxandr P. Malyarchuk
11 Volokolamskoe highway, Moscow, 125080, Russian Federation
References
1. Baker, C. J. (2013). Red Book atlas of pediatric infectious diseases. American Academy of Pediatrics.
2. Currie, B. J., & McCarthy, J. S. (2010). Permethrin and ivermectin for scabies. New England Journal of Medicine, 362(8), 717-725.
3. Executive Committee of Guideline for the Diagnosis. (2017). Guideline for the diagnosis and treatment of scabies in Japan: Executive Committee of Guideline for the Diagnosis and Treatment of Scabies. Journal of Dermatology, 44(9), 991-1014.
4. Kazeminejad, A., & Ghahari, M. J.(2019) Scabies Treatment in Children: A Narrative Review. Journal Pediatrics Review, 7(2), 105-112.
5. Mytton, O., Mcgready, R., Lee, S., Roberts, C., Ashley, E., Carrara, V., Thwai, K. L., Jay, M. P., Wiangambun, T., Singhasivanon, P., & Nosten, F. (2007). Safety of benzyl benzoate lotion and permethrin in pregnancy: a retrospective matched cohort study. BJOG an International Journal of Obstetrics & Gynaecology. BJOG An International Journal of Obstetrics & Gynaecology. http://doi.org/10.1111/j.1471-0528.2007.01290. xRosumeck, S., Nast, A., & Dressler, C. (2018). Ivermectin and permethrin for treating scabies. Cochrane Database of Systematic Reviews, (4). http://dx.doi.org/10.1002/14651858.CD012994
6. Salavastru, C. M., Chosidow, O., Boffa, M. J., Janier, M., & Tiplica, G. S. (2017). European guideline for the management of scabies. Journal of the European Academy of Dermatology and Venereology, 31(8), 1248-1253.
7. Strong M., & Johnstone, P. (2011). Cochrane Review: Interventions for treating scabies. Evidence-Based Child Health: A Cochrane Review Journal, 6(6). https://doi.org/10.1002/ebch.861
8. Strong, M., & Johnstone, P. (2007). Interventions for treating scabies. Cochrane Database of Systematic Reviews, (3).
9. Strong, M., & Johnstone, P. (2010). Interventions for treating scabies (Review), The Cochrane Collaboration, 1-70.
10. Sunderkötter, C., Aebischer, A., Neufeld, M., Löser, C., Kreuter, A., Bialek, R., Hamm, H., & Feldmeier, H. (2019). Increase of scabies in Germany and development of resistant mites? Evidence and consequences. Journal der Deutschen Dermatologischen Gesellschaft [Journal of the German Society of Dermatology], 17(1), 15–23. https://doi.org/10.1111/ddg.13706
11. Thadanipon, K., Anothaisintawee, T., Rattanasiri, S., Thakkinstian, A., & Attia, J. (2019). Efficacy and safety of antiscabietic agents: A systematic review and network meta-analysis of randomized controlled trials. Journal of the American Academy of Dermatology, 80(5), 1435-1444.
12. Usha, V., & Nair, T. G. (2000). A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. Journal of the American Academy of Dermatology, 42(2), 236-240.
13. Van der Rhee, H. J., Farquhar, J. A., & Vermeulen, N. P. (1989). Efficacy and transdermal absorption of permethrin in scabies patients. Acta dermato-venereologica, 69(2), 170-176.
14. Wendel, K., & Rompalo, A. (2002). Scabies and pediculosis pubis: an update of treatment regimens and general review. Clinical Infectious Diseases, 35(Supplement_2), S146-S151.
15. Workowski, K. A., Berman, S. (2010). Sexually Transmitted Diseases Treatment Guidelines, 2010. Morbidity and Mortality Weekly Report, 59(12), 89–90.
16. Malyarchuk, A. P. (2006). Optimizaciya diagnostiki, lecheniya i profilaktike chesotki [Optimization of diagnosis, treatment and prevention of scabies] [Malyarchuk, Aleksandr Petrovich. Avtoref. diss… kand. med. nauk. GIUV MO RF]. Moskva. Rossiya.
17. Malyarchuk, A. P. (2014). The effect of various concentrations of medifox on the effectiveness of scabies treatment. Dermatologiya v Rossii [Dermatology in Russia], 3(1). URL: http://www.dermatology.ru/publications/derm.ross. 2014.01/31424/.
18. Olifer, V. V. (2006). Novye podhody k razrabotke skabicidnyh sredstv i sovershenstvovanie profilakticheskih meropriyatij v ochagah chesotki [New approaches to the development of scabicidal agents and the improvement of preventive measures in foci of scabies] [Olifer, Veronika Valentinovna. Avtoref. diss…kand.biol.nauk. PMGMU MZ RF]. Moskva. Rossiya.
19. Ryazancev, I. V. (2004). Sovershenstvovanie lechebno- profilakticheskih meropriyatij pri chesotke v VS RF [Improving treatment and preventive measures for scabies in the Armed Forces of the Russian Federation] [Ryazancev, Ivan Valer’evich. Avtoref. diss…kand.med.nauk. GIUV MO RF]. Moskva. Rossiya.
20. Sokolova, T. V., & Malyarchuk, A. P. (2009). Therapy of scabies. Klinicheskaya dermatologiya i venerologiya [Clinical Dermatology and Venereology], 6, 64-67.
Review
For citations:
Sokolova T.V., Malyarchuk A.P. Children’s Scabies. Problem to be Solved. Health, Food & Biotechnology. 2019;1(4):19-25. (In Russ.) https://doi.org/10.36107/hfb.2019.i4.s252
Views:
508
Email this article 